Vinay Prasad, MD, former head of the FDA’s vaccine and gene therapy division who resigned under political pressure two weeks ago, is returning to the agency, The New York Times reported Aug. 9. Dr. Prasad stepped down from the role in late July following criticism from right-wing influencer Laura Loomer,

Iran has had limited IAEA inspections in the past as a pressure tactic in negotiating with the West, and it is unclear how soon talks between Tehran and Washington for a deal over its nuclear programme will resume.